SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 196 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,772,000 | -22.2% | 211,698 | -15.9% | 0.28% | -26.2% |
Q3 2019 | $2,278,000 | -16.0% | 251,698 | 0.0% | 0.38% | -11.7% |
Q2 2019 | $2,711,000 | +19.0% | 251,698 | +5.4% | 0.44% | +19.5% |
Q1 2019 | $2,279,000 | +28.1% | 238,857 | +54.1% | 0.36% | +22.1% |
Q4 2018 | $1,779,000 | -32.3% | 154,960 | 0.0% | 0.30% | -27.4% |
Q3 2018 | $2,627,000 | +26.7% | 154,960 | +6.1% | 0.41% | +19.4% |
Q2 2018 | $2,073,000 | +13.7% | 146,000 | +52.1% | 0.34% | +4.9% |
Q1 2018 | $1,824,000 | – | 96,000 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |